• Transcriptional Elongation Inhibition at the Frontier of ...

  2025-10-22

  Explore the transformative role of 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) as a transcriptional elongation and CDK inhibitor in shaping cell fate, advancing HIV and antiviral research, and unlocking new avenues in stem cell and cancer biology. This thought-leadership article synthesizes mechanistic insights, emerging scientific evidence, and strategic recommendations for translational researchers, positioning DRB as a catalyst for next-generation discovery.

• Mitomycin C: Mechanistic Precision and Translational Powe...

  2025-10-21

  Mitomycin C, a gold-standard antitumor antibiotic and DNA synthesis inhibitor, is transforming apoptosis signaling research and translational oncology. This thought-leadership article provides mechanistic insight into its role as a TRAIL-induced apoptosis potentiator, strategic guidance for experimental design, and a forward-looking vision for its integration into next-generation combination therapies. By contextualizing Mitomycin C within the evolving landscape of DNA-damaging agents and referencing recent antiviral genome-editing breakthroughs, this article charts new territory for innovative translational researchers.

77 records 6/6 page Previous First page 上5页 6